Arkimedica Group, a leading Group in the field of health care and medical products developed by Cape Natexis Fund, has completed an acquisition through its subsidiary Delta Med (Medical Devices Division) with a view to listing on the Expandi segment of the Milan Stock Exchange.

Delta Med acquired for an amount of 2.4 million euros 60 percent of Dirra's share capital.

“The investment in Dirra is justified with a view to Arkimedica Group's long-term strategy that allows for the improvement and, above all, the expansion of its product and service offerings. In fact, the goal is to make Arkimedica the first district company in the medical field since, in Italy, there is still no listed company active in health care and medical products,” says Simone Cimino, president of Arkimedica.

Advisor for the Dirra transaction was K Finance.

Delta Med is a company active in the production and distribution of disposable medical devices.

Dirra is a company active in the production and distribution of nonwoven (TNT) disposable medical products. In recent years, it has seen steady growth in both operating profits and turnover, which stands at 4.2 million.